Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer.

Baroz AR, Mambetsariev I, Fricke J, Pharaon R, Tan T, Kidambi T, Sandhu KS, Koczywas M, Salgia R. Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer. Cureus. 2021 Jul; 13(7):e16266.

View in: PubMed

collapse authors with profiles